Daptomycin is a cyclic lipopeptide antibiotic with a calcium-dependent mechanism that disrupts Gram-positive bacterial cell-membrane potential, used intravenously for MRSA bacteraemia, endocarditis and complicated skin infections. Simson Pharma's Daptomycin reference standard and impurities support the precise potency control this calcium-mediated injectable antibiotic demands.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Daptomycin Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.